Patient with novel coronavirus COVID-19 in the Netherlands A patient in the Netherlands was diagnosed with the novel coronavirus (COVID-19). Tests confirmed this today.
German coronavirus patient not sick during stay in Limburg On Tuesday evening 25 February, it was announced that a German man was tested positive for COVID-19. He would have been in the Netherlands last week.
Mesh implants intended to treat pelvic organ prolapse Synthetic mesh are used to treat patients with pelvic organ prolapse.
First results Plastic Pact Netherlands The Dutch Plastic Pact (Plastic Pact NL) was launched in the Netherlands in February 2019, and it is the first step to make single-use plastic products and packaging more sustainable and suitable f
RIVM welcomes German Federal Centre for Health Education Today RIVM’s Centre for Healthy Living (CGL) welcomes the Bundeszentrale für gesundheitliche Aufklärung.
Scientific background information on rubber granulate now available in English In December 2016, RIVM published in Dutch the results of its research into the health risks of playing sports on synthetic turf pitches with rubber granulate.
Environmentally harmful pharmaceuticals cannot be replaced yet RIVM investigates how the impact of pharmaceutical residues on the environment may be reduced.
Off-label use of medicinal products in the European Union Off-label use of medicinal products in the European Union is common, both in primary and in secondary care.
Learn how students can contribute to research from NASA, KNMI, RIVM and WUR The Global Learning and Observation to Benefit the Environment (GLOBE) program in the Netherlands (GLOBE Netherlands) is organising the annual GLOBE day on 21 March .
Age and vaccination history affect immune responses after natural infection with whooping cough Age plays a role in immune responses after a natural infection with Bordetella pertussis, the bacterium that causes the contagious respiratory infection pertussis (whooping cough).